Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

2015 January 29 | Silvana Konermann, Mark D. Brigham, Alexandro E. Trevino, Julia Joung, Omar O. Abudayyeh, Clea Barcena, Patrick D. Hsu, Naomi Habib, Jonathan S. Gootenberg, Hiroshi Nishimasu, Osamu Nureki, and Feng Zhang
The authors describe the structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. They demonstrate that this engineered complex can activate multiple genes simultaneously and upregulate long intergenic non-coding RNA (lincRNA) transcripts. The authors also synthesize a library of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that confer resistance to a BRAF inhibitor when activated. The results show that the top hits are enriched in genes that are validated using individual sgRNA and cDNA overexpression. The authors conclude that the CRISPR-based gain-of-function screening approach is a powerful tool for functional genomics research.The authors describe the structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. They demonstrate that this engineered complex can activate multiple genes simultaneously and upregulate long intergenic non-coding RNA (lincRNA) transcripts. The authors also synthesize a library of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that confer resistance to a BRAF inhibitor when activated. The results show that the top hits are enriched in genes that are validated using individual sgRNA and cDNA overexpression. The authors conclude that the CRISPR-based gain-of-function screening approach is a powerful tool for functional genomics research.
Reach us at info@study.space